Safety and Efficacy of ALC in Breast Cancer in Subjects With Fatigue

NCT00555841 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

27

Enrollment

INDUSTRY

Sponsor class

Stopped Sponsor decision

Conditions

Breast Cancer

Interventions

DRUG: ALC and Placebo

Sponsor

Sigma-Tau Research, Inc.